Skip to main content
Journal cover image

The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).

Publication ,  Journal Article
Ruwald, A-C; Pietrasik, G; Goldenberg, I; Kutyifa, V; Daubert, JP; Ruwald, MH; Jons, C; McNitt, S; Wang, P; Zareba, W; Moss, AJ
Published in: J Am Coll Cardiol
April 1, 2014

OBJECTIVES: This study aimed to investigate the effect of both history of intermittent atrial tachyarrhythmias (IAT) and in-trial IAT on the risk of heart failure (HF) or death comparing cardiac resynchronization therapy with defibrillator (CRT-D) to implantable cardioverter-defibrillator (ICD) treatment in mildly symptomatic HF patients with left bundle branch block (LBBB). BACKGROUND: Limited data exist regarding the benefit of CRT-D in patients with IAT. METHODS: The benefit of CRT-D in reducing the risk of HF/death was evaluated using multivariate Cox models incorporating the presence of, respectively, a history of IAT at baseline and time-dependent development of in-trial IAT during follow-up in 1,264 patients with LBBB enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy) study. RESULTS: The overall beneficial effect of CRT-D versus ICD on the risk of HF/death was not significantly different between LBBB patients with or without history of IAT (HR: 0.50, p = 0.028, and HR: 0.46, p < 0.001, respectively; p for interaction = 0.79). Among patients who had in-trial IAT, CRT-D was associated with a significant 57% reduction in the risk of HF/death compared with ICD-only therapy (HR: 0.43, p = 0.047), similar to the effect of the device among patients who did not have IAT (HR: 0.47, p < 0.001; p for interaction = 0.85). The percentage of patients with biventricular pacing ≥92% was similar in both groups (p = 0.43). Consistent results were shown for the benefit of CRT-D among patients who had in-trial atrial fibrillation/flutter (HR: 0.30, p = 0.027; p for interaction = 0.41). CONCLUSIONS: In the MADIT-CRT study, the clinical benefit of CRT-D in LBBB patients was not attenuated by prior history of IAT or by the development of in-trial atrial tachyarrhythmias. (MADIT-CRT: Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy; NCT00180271).

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Am Coll Cardiol

DOI

EISSN

1558-3597

Publication Date

April 1, 2014

Volume

63

Issue

12

Start / End Page

1190 / 1197

Location

United States

Related Subject Headings

  • Ultrasonography
  • Tachycardia
  • Multivariate Analysis
  • Middle Aged
  • Male
  • Kaplan-Meier Estimate
  • Humans
  • Heart Failure
  • Heart Atria
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ruwald, Anne-Christine, Grzegorz Pietrasik, Ilan Goldenberg, Valentina Kutyifa, James P. Daubert, Martin H. Ruwald, Christian Jons, et al. “The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).J Am Coll Cardiol 63, no. 12 (April 1, 2014): 1190–97. https://doi.org/10.1016/j.jacc.2013.10.074.
Journal cover image

Published In

J Am Coll Cardiol

DOI

EISSN

1558-3597

Publication Date

April 1, 2014

Volume

63

Issue

12

Start / End Page

1190 / 1197

Location

United States

Related Subject Headings

  • Ultrasonography
  • Tachycardia
  • Multivariate Analysis
  • Middle Aged
  • Male
  • Kaplan-Meier Estimate
  • Humans
  • Heart Failure
  • Heart Atria
  • Female